Group 1 - Zhaoyi Innovation plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders and market conditions [3] - ST Zhongdi has decided to abandon the commercial opportunity for the Jiageng Ke Yi City land project, with the controlling shareholder planning to develop the project instead [4] - Xichang Electric Power expects a reduction of approximately 5.4 million yuan in net profit for 2025 due to adjustments in the time-of-use electricity pricing mechanism [5] Group 2 - Sanfu New Materials intends to invest 620 million yuan in a project for high-safety dry electrode battery key materials and high-frequency electronic information composite materials [6] - Weifu High-Tech's subsidiary plans to establish a joint venture with Baolong Technology to expand the active suspension motor hydraulic pump business [7] - Yulong Co., Ltd. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [8] Group 3 - Chen'an Technology's shareholder is transferring 6.27% of the company's shares to Hefei Guotou, aiming to introduce strategic investors [9] - Huamao Technology is planning to acquire a 100% stake in Fuchuang Youyue, with stock trading suspended for up to 10 trading days [11] - Baolong Technology's subsidiary will collaborate with Weifu High-Tech's subsidiary to develop core components for the active suspension system [12] Group 4 - Zhongnong Lihua intends to acquire at least 50% of Taizhou Agricultural Supplies, enhancing its product and service range [13] - Weiling Co., Ltd.'s subsidiary has successfully acquired 74.3% of Jiayu Mining for 220 million yuan, focusing on expanding into the non-ferrous metal resource sector [14][15] - Hengshi Technology's subsidiary has been approved for public transfer of shares on the New Third Board [16] Group 5 - Xiang Teng New Materials plans to acquire an additional 12.5% stake in its subsidiary Shanghai Shangda for 25.3 million yuan [17] - ST Texin has extended its employee stock ownership plan by 12 months, reflecting confidence in the company's long-term development [18] - Baili Electric has issued a risk warning regarding its stock price increase, indicating no significant changes in fundamentals [19] Group 6 - Hu Silicon Industry plans to acquire minority stakes in three semiconductor companies for approximately 7.04 billion yuan [20][21] - Demais plans to change its controlling shareholder, leading to a temporary suspension of stock trading [22] - FAW Fuwei has received a notice from a well-known new energy brand for a project expected to generate 1.06 billion yuan in total sales over its lifecycle [23] Group 7 - Hangyang Co. plans to establish a subsidiary for a large modular cryogenic equipment manufacturing project with an estimated investment of 557 million yuan [24] - Jiewate intends to acquire 40.89% of Tianyi Hexin for 319 million yuan, enhancing its product line in the signal chain category [25] - Dingxin Communications has elected a new chairman following the resignation of the previous chairman [26][27] Group 8 - Aofei Entertainment plans to invest 10 million yuan in a partnership to indirectly invest in AI robotics company Xuan Yuan Technology [28] - Huaxi Energy's controlling shareholder has been detained, but the company states that operations remain normal [29] - Yihe Jiaye will change its stock name to "Ruimaite" starting May 21 [30] Group 9 - Zhongjin Environment will change its name to "Southern Pump Industry" effective May 21 [31] - Hong Sifang's subsidiary plans to invest approximately 1.49 billion yuan in a new chemical materials and fertilizers industrial park [32] - Buchang Pharmaceutical's subsidiary has signed a research agreement for MF59 adjuvant with a pharmaceutical company [33] Group 10 - Hongjing Technology has signed a service contract worth 597 million yuan for a smart computing project [34] - Zhuojin Co. has won a bid for a soil remediation project worth 67.68 million yuan [35] - Xinjiang Jiaojian has been awarded a contract for a highway project valued at 451 million yuan [36] Group 11 - China National Materials Energy's subsidiary has signed a contract for an EPC project in Uzbekistan worth approximately 1.252 billion yuan [37] - Ruixin Microelectronics' shareholder plans to reduce its stake by up to 2% [38] - Shanghai Yizhong's shareholder also plans to reduce its stake by up to 2% [39] Group 12 - Sanyou Medical's controlling shareholder plans to reduce its stake by up to 1.44% [40] - Hangdian Co.'s controlling shareholder plans to reduce its stake by up to 1.93% [41] - Shangwei New Materials' shareholder plans to reduce its stake by up to 3% [42] Group 13 - Mingchen Health plans to repurchase shares worth between 30 million and 50 million yuan [43] - Jiuhua Tourism plans to raise up to 500 million yuan through a private placement for various projects [44] - Yuegui Co. plans to raise up to 900 million yuan for several projects [46]

Group 1 - Zhaoyi Innovation plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders and market conditions [3] - ST Zhongdi has decided to abandon the commercial opportunity for the Jiageng Science and Art City land project, which has an area of 108,600 square meters and a starting price of 2.067 billion yuan [4] - Xichang Electric Power expects a reduction of approximately 5.4 million yuan in net profit for 2025 due to adjustments in the time-of-use electricity pricing mechanism [5] Group 2 - Sanfu New Technology plans to invest 620 million yuan in a project for high-safety dry electrode battery key materials and high-frequency electronic information composite materials, with production expected to start in June 2025 [6] - Weifu High-Tech's subsidiary will establish a joint venture with Baolong Technology to expand the business of fully active suspension motor hydraulic pumps, with a registered capital of 400 million yuan [7] - Yulong Co., Ltd. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [8] Group 3 - Chensan Technology's shareholder Shanghai Ruiwei will transfer 14.58 million shares, representing 6.27% of the company, to Hefei Guotou, with the transfer price set at 17.7 yuan per share [10] - Huamao Technology is planning to acquire a 100% stake in Fuchuang Youyue, currently holding 42.16% of the company, with stock trading suspended for up to 10 days [11] - Baolong Technology's subsidiary will partner with Weifu High-Tech's subsidiary to develop and mass-produce core components for fully active suspension systems [12] Group 4 - Buchang Pharmaceutical's subsidiary has signed a commissioned research agreement with Fubicheng Pharmaceutical for the MF59 emulsion adjuvant [14] - Hongjing Technology has signed a service contract worth 597 million yuan for a smart computing project, with a duration of five years [15] - Zhuojin Co., Ltd. has won a bid for a soil remediation project worth 67.68 million yuan, with an expected share of approximately 59.9 million yuan [16] - Xinjiang Jiaojian has been awarded a contract for the G3013 line Ucha to Kangsou highway project, with a bid amount of 451 million yuan [17] Group 5 - Mingchen Health plans to repurchase shares worth between 30 million and 50 million yuan for employee stock ownership plans, with a maximum repurchase price of 23 yuan per share [19]

证券代码：002919 证券简称：名臣健康 公告编号：2025-014 名臣健康用品股份有限公司 关于回购公司股份方案的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 1、拟回购股份的种类：名臣健康用品股份有限公司（以下简称"公司"）已 发行的人民币普通股（A股）股票。 2、回购股份用途：将用于公司股权激励计划或员工持股计划。 3、回购股份的价格区间、数量、占总股本的比例及用于回购的资金总额：本 次回购股份价格不超过人民币23元/股（含），回购资金金额不低于人民币3,000 万元（含）且不超过人民币5,000万元（含），在回购股份价格不超过人民币23 元/股（含）的条件下，按回购金额、价格上限测算，预计回购股份数量约为 2,173,913股，约占公司目前已发行总股本的0.8156%；按回购金额下限、回购价 格上限测算，预计回购股份数量约为1,304,347股，约占公司目前已发行总股本 的0.4894%。具体回购股份的数量以回购期满时实际回购的股份数量为准。 4、相关股东是否存在减持计划 公司董事、监事、高级管理人员，控股股东、实际控制人及 ...

北京市君泽君（深圳）律师事务所 关于名臣健康用品股份有限公司 2024 年年度股东大会的法律意见书 深圳市福田区金田路4028号荣超经贸中心28层、29层 邮政编码：518035 电话：（0755）33988188 28&29 Floor, Rongchao Economic Trade Center, No.4028 Jintian Rd, Futian District,Shenzhen 518035 Tel：（0755）33988188 北京市君泽君（深圳）律师事务所 关于名臣健康用品股份有限公司 2024 年年度股东大会的法律意见书 致：名臣健康用品股份有限公司 名臣健康用品股份有限公司（以下简称"公司"）2024 年年度股东大会（以下 简称"本次股东大会"）于 2025 年 5 月 20 日 13：30 召开，北京市君泽君（深圳） 律师事务所（以下简称"本所"）接受公司的委托，指派相关律师（以下简称"本所律 师"）出席会议，并依据中国证券监督管理委员会（以下简称"中国证监会"）《上市 公司股东会规则》（以下简称"《股东会规则》"）的要求发表法律意见并出具本法 律意见书。 为出具本法律意见书，本所律师 ...

证券代码：002919 证券简称：名臣健康 公告编号：2025-015 名臣健康用品股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 1、会议召开情况 （1）现场会议召开时间：2025 年 5 月 20 日（星期二）下午 13:30 （2）网络投票时间：2025 年 5 月 20 日 其中：通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 5 月 20 日上午 9:15-9:25、9:30-11:30，下午 13:00-15:00；通过深圳证券交易所互联 网投票系统投票时间为 2025 年 5 月 20 日 9:15-15:00 期间的任意时间。 （3）现场会议召开地点：广东省汕头市澄海区莲南工业区名臣健康用品股 份有限公司二楼会议室。 （5）会议召集人：公司董事会 （6）现场会议主持人：董事长陈建名先生 （7）会议召集、召开的合法、合规性：本次股东大会的召集、召开符合有 关 ...

证券代码：002919 证券简称：名臣健康 公告编号：2025-013 名臣健康用品股份有限公司 第四届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 名臣健康用品股份有限公司(以下简称"公司")第四届董事会第五次会议于 2025年5月20日在公司二楼会议室以现场和视频通讯方式召开，会议通知以专人 送达、传真、电子邮件、电话相结合的方式已于2025年5月15日向各位董事发出。 本次会议由董事长兼总经理陈建名先生主持。本次会议应出席董事7名，实际出 席董事7名(其中：董事梁锦辉先生以通讯方式参会)，公司监事列席会议。本次 会议的召开符合《公司法》、《公司章程》等法律法规的规定，合法有效。 二、 董事会会议审议情况 1.1 回购股份的目的和用途 基于对公司价值的判断和未来发展的信心，立足公司长期可持续发展和价值 增长，增强投资者对公司的投资信心，结合公司发展战略、经营情况和财务状况， 公司根据《公司法》《证券法》等法律法规及《公司章程》规定，拟回购公司股 份，以推进公司股票市场价格与内在价值相匹配。 1、逐项审议通 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 三、会议登记事项 1、登记方式：现场登记、书面信函或传真方式登记。 （1）自然人股东登记：自然人股东须持本人身份证（原件）、证券账户卡（复印件）办理登记手续； 委托代理人出席的应持代理人身份证（原件）、授权委托书（原件，见附件1）、委托人身份证（复印 件）和委托人证券账户卡（复印件）办理登记手续； （2）法人股东登记：法人股东由法定代表人出席会议的，须持本人身份证（原件）、营业执照（复印 件加盖公章）、法定代表人身份证明书（原件）和证券账户卡（复印件）办理登记手续；由法定代表人 委托的代理人出席会议的，持代理人身份证（原件）、法定代表人身份证（复印件）、营业执照（复印 件加盖公章）、法定代表人身份证明书（原件）、授权委托书（原件，法定代表人签署并加盖公章，见 附件1）和证券账户卡（复印件）办理登记手续； （3）异地股东可以凭上述文件以书面信函或传真方式办理登记。 拟出席本次会议的股东应将上述材料及股东大会参会股东登记表（见附件2）以专人送达、信函或传真 方式送达本公司。 2、登记时间： （1）现场登记时间：2025年5月15日（星期四）上午9:00-11:30 ...

Core Viewpoint - The company, Mingchen Health Products Co., Ltd., has released its 2024 annual report summary, highlighting its business performance, financial status, and future development plans. The report indicates a shift in the company's business model from a single focus on daily chemical products to a dual focus that includes online gaming, following the acquisition of gaming companies in 2020 [1][4]. Group 1: Company Overview - Mingchen Health was established in 1994 and successfully listed on the Shenzhen Stock Exchange in December 2017. The company has transitioned to a dual business model, incorporating both daily chemical products and online gaming [4][5]. - The main products in the daily chemical segment include shampoos, conditioners, body washes, and skincare products, with a focus on consumer needs and product quality [5][8]. - In the gaming segment, the company operates through subsidiaries engaged in game development and publishing, with a commitment to creating high-quality games [6][9]. Group 2: Financial Performance - For the fiscal year 2024, the company reported a total revenue of 1.380 billion yuan, a decrease of 15.71% compared to the previous year. The operating profit was 31.33 million yuan, down 45.92%, and the net profit attributable to shareholders was 46.72 million yuan, a decline of 33.60% [31][34]. - The company plans to distribute a cash dividend of 0.5 yuan per share, totaling approximately 13.31 million yuan, without any capital reserve conversion [35][36]. Group 3: Future Outlook - The company has set a revenue target for 2025 between 1.5 billion to 1.8 billion yuan, representing a year-on-year growth of 8.70% to 30.44%. The net profit target for 2025 is set between 80 million to 120 million yuan, indicating a significant potential increase of 71.25% to 156.87% compared to 2024 [34][35]. - The company is also focusing on enhancing its internal control systems and has received a clean audit report for its internal controls, which reflects its commitment to maintaining operational integrity [39][40].

名臣健康用品股份有限公司 2024 年度独立董事述职报告 本人作为名臣健康用品股份有限公司（以下简称"公司"）的独立董事， 根据《公司法》《上市公司独立董事管理办法》（以下简称"《独董管理办 法》"）《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司 规范运作》（以下简称"《主板上市公司规范运作》"）等法律法规及《名 臣健康用品股份有限公司章程》（以下简称"《公司章程》"）《独立董事 工作制度》等公司制度规定，认真行使法规所赋予的权利，及时了解公司的 经营管理信息，全面关注公司的发展状况，积极出席公司 2024 年度召开的相 关会议，对董事会审议事项进行了审核，列席股东大会，忠实履行职责，充 分发挥独立董事的独立作用，维护了公司及全体股东尤其是中小股东的合法 利益。 报告期内，本人因公司第四届董事会换届选举，自 2024 年 5 月 20 日起 聘任本人为公司独立董事。现将本人在 2024 年任职期间履行职责情况述职如 下： 一、 独立董事的基本情况 1、个人基本情况 本人陈景华，本科学历，会计专业。2020 年 9 月-2021 年 11 月担任大信 会计师事务所（特殊普通合伙）经理、2021 ...

名臣健康用品股份有限公司 二、 独立董事年度履职情况 2024 年度独立董事述职报告 本人作为名臣健康用品股份有限公司（以下简称"公司"）的独立董事， 根据《公司法》《上市公司独立董事管理办法》（以下简称"《独董管理办 法》"）《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司 规范运作》（以下简称"《主板上市公司规范运作》"）等法律法规及《名 臣健康用品股份有限公司章程》（以下简称"《公司章程》"）《独立董事 工作制度》等公司制度规定，认真行使法规所赋予的权利，及时了解公司的 经营管理信息，全面关注公司的发展状况，积极出席公司 2024 年度召开的相 关会议，对董事会审议事项进行了审核，列席股东大会，忠实履行职责，充 分发挥独立董事的独立作用，维护了公司及全体股东尤其是中小股东的合法 利益。现将本人在 2024 年度履行职责情况述职如下： （一） 出席董事会及股东大会情况 一、 独立董事的基本情况 1、个人基本情况 本人吴小艳，博士研究生。曾任职于武汉工业大学助教、武汉理工大学 讲师、武汉理工大学副教授、上汽通用五菱股份有限公司博士后，现任武汉 理工大学副教授。2021 年 5 月起担任名臣健康 ...